Related Experiment Video

Updated: May 18, 2026

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
03:05

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia

Published on: February 16, 2024

Postoperative vomiting in pediatric oncologic patients: prediction by a fuzzy logic model

Betina S B Bassanezi1, Antônio G de Oliveira-Filho, Rosana S M Jafelice

  • 1Department of Anesthesiology, Centro Infantil Boldrini, Campinas, SP, Brazil. bbassanezi@gmail.com

Paediatric Anaesthesia
|September 25, 2012
PubMed

Insights

A new fuzzy logic model accurately predicts postoperative vomiting (POV) in pediatric cancer patients, outperforming existing scores. This tool aids in planning anti-vomiting treatments for better patient outcomes.

Area of Science:

  • Oncology
  • Anesthesiology
  • Artificial Intelligence

Background:

  • Postoperative vomiting (POV) is common in children, impacting parental satisfaction.
  • Existing predictive scores for pediatric POV are limited, with Eberhart's score being the primary tool.
  • Fuzzy logic offers a nuanced approach to modeling, accommodating continuous variables and subjectivity.

Purpose of the Study:

  • To develop and present a fuzzy logic mathematical model for predicting POV in pediatric oncologic patients.
  • To compare the predictive performance of the fuzzy logic model against established scores.

Main Methods:

  • Analysis of preoperative risk factors in 198 pediatric oncology patients (0-19 years).
  • Identification of probable risk factors using chi-square and logistic regression.
  • Development of a fuzzy logic system and a computational interface for POV probability calculation.

Main Results:

  • The fuzzy logic model demonstrated strong performance in predicting POV.
  • Comparison revealed the fuzzy model outperformed Eberhart's score in the studied population.

Conclusions:

  • The developed fuzzy score accurately predicts the likelihood of POV in pediatric cancer patients.
  • This model facilitates improved planning for postoperative anti-vomiting prophylaxis.
  • A user-friendly computational interface is freely available online.
Abstract

Related Concept Videos

Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through interaction...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Pyloric Obstruction01:11

Pyloric Obstruction

Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant, half-life,...